Lu B - Search Results

1

Amphiregulin couples IL1RL1⁺ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity.

Sun R, Zhao H, Gao DS, Ni A, Li H, Chen L, Lu X, Chen K, Lu B. Sun R, et al. Among authors: lu x, lu b. Sci Adv. 2023 Aug 25;9(34):eadd7399. doi: 10.1126/sciadv.add7399. Epub 2023 Aug 23. Sci Adv. 2023. PMID: 37611111 Free PMC article.

2

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment.

Yang M, Du W, Yi L, Wu S, He C, Zhai W, Yue C, Sun R, Menk AV, Delgoffe GM, Jiang J, Lu B. Yang M, et al. Among authors: lu b. Oncoimmunology. 2020 Jan 30;9(1):1708064. doi: 10.1080/2162402X.2019.1708064. eCollection 2020. Oncoimmunology. 2020. PMID: 32076578 Free PMC article.

3

Tumor-Derived IL33 Promotes Tissue-Resident CD8⁺ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy.

Chen L, Sun R, Xu J, Zhai W, Zhang D, Yang M, Yue C, Chen Y, Li S, Turnquist H, Jiang J, Lu B. Chen L, et al. Among authors: lu b. Cancer Immunol Res. 2020 Nov;8(11):1381-1392. doi: 10.1158/2326-6066.CIR-19-1024. Epub 2020 Sep 11. Cancer Immunol Res. 2020. PMID: 32917659 Free PMC article.

4

Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis.

Gao L, Li B, Wang J, Shen D, Yang M, Sun R, Tung HC, Xu M, Ren S, Zhang M, Yang D, Lu B, Wang H, Liu Y, Xie W. Gao L, et al. Among authors: lu b. Hepatol Commun. 2020 Aug 12;4(11):1664-1679. doi: 10.1002/hep4.1584. eCollection 2020 Nov. Hepatol Commun. 2020. PMID: 33163836 Free PMC article.

5

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8⁺ T Cells.

Sun R, Wu Y, Zhou H, Wu Y, Yang Z, Gu Y, Jiang J, Lu B, Zhu Y. Sun R, et al. Among authors: lu b. Front Cell Dev Biol. 2021 Jan 21;9:640224. doi: 10.3389/fcell.2021.640224. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33553191 Free PMC article.

6

A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death.

Huang H, Huang Y, Chen Y, Luo Z, Zhang Z, Sun R, Wan Z, Sun J, Lu B, Zhang L, Hu J, Li S. Huang H, et al. Among authors: lu b. Biomaterials. 2021 Mar;270:120708. doi: 10.1016/j.biomaterials.2021.120708. Epub 2021 Feb 4. Biomaterials. 2021. PMID: 33578254 Free PMC article.

7

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination.

Chen Y, Huang Y, Huang H, Luo Z, Zhang Z, Sun R, Wan Z, Sun J, Lu B, Li S. Chen Y, et al. Among authors: lu b. Mol Ther Nucleic Acids. 2021 Sep 20;26:594-602. doi: 10.1016/j.omtn.2021.09.006. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34703645 Free PMC article.

8

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy.

Wu S, Sun R, Tan B, Chen B, Zhou W, Gao DS, Zhong J, Huang H, Jiang J, Lu B. Wu S, et al. Among authors: lu b. Front Cell Dev Biol. 2021 Nov 15;9:779865. doi: 10.3389/fcell.2021.779865. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34869384 Free PMC article.

9

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy.

Wan Z, Sun R, Liu YW, Li S, Sun J, Li J, Zhu J, Moharil P, Zhang B, Ren P, Ren G, Zhang M, Ma X, Dai S, Yang D, Lu B, Li S. Wan Z, et al. Among authors: lu b. Sci Adv. 2021 Dec 10;7(50):eabj4226. doi: 10.1126/sciadv.abj4226. Epub 2021 Dec 10. Sci Adv. 2021. PMID: 34890233 Free PMC article.

10

The IL-1 family in tumorigenesis and antitumor immunity.

Sun R, Gao DS, Shoush J, Lu B. Sun R, et al. Among authors: lu b. Semin Cancer Biol. 2022 Nov;86(Pt 2):280-295. doi: 10.1016/j.semcancer.2022.05.002. Epub 2022 May 14. Semin Cancer Biol. 2022. PMID: 35580824 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,660 results

Search Page